Tannic Acid 单宁酸

CAS 1401-55-4 MFCD00066397

化学结构图

1401-55-4
SMILES: O=C(OC[C@H]1O[C@@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@@H]1OC(=O)c1cc(O)c(O)c(OC(=O)c2cc(O)c(O)c(O)c2)c1)c1cc(O)c(O)c(OC(=O)c2cc(O)c(O)c(O)c2)c1

化学属性

Mol. FormulaC76H52O46
Mol. Weight
Autoignition Point980 °F
Melting PointNo Data Available
Flash Point-
SolubilitySoluble in water, warm glycerol, alcohol, acetone
TSCAYes
Density2.12
Stability对光敏感
Boiling Point

别名和识别编码

Chemical NameTannic Acid
MDL Number-
CAS Number1401-55-4
Synonym (2S,3R,4S,5R,6R)-3,4,5-tris(3,4-dihydroxy-5-(3,4,5-trihydroxybenzoyloxy)benzoyloxy)-6-((3,4-dihydroxy-5-(3,4,5-trihydroxybenzoyloxy)benzoyloxy)methyl)oxan-2-yl 3,4-dihydroxy-5-(3,4,5-trihydroxybenzoyloxy)benzoate Acid, Tannic Acids, Tannic Castanea sativa Mill tannin Gallotannic Acid Gallotannic acid Gallotannin Glycerite TERRI PODS GALLOTANNIN Tannic Acid {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} { {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {} {}
Beilstein Registry Number8186396
PubChem Substance ID16129778
EC Number215-753-2
Merck Number14,9052
Chemical Name Translation单宁酸
LabNetwork Molecule IDLN01300301
InChIInChI=1S/C76H52O46/c77-32-1-22(2-33(78)53(32)92)67(103)113-47-16-27(11-42(87)58(47)97)66(102)112-21-52-63(119-72(108)28-12-43(88)59(98)48(17-28)114-68(104)23-3-34(79)54(93)35(80)4-23)64(120-73(109)29-13-44(89)60(99)49(18-29)115-69(105)24-5-36(81)55(94)37(82)6-24)65(121-74(110)30-14-45(90)61(100)50(19-30)116-70(106)25-7-38(83)56(95)39(84)8-25)76(118-52)122-75(111)31-15-46(91)62(101)51(20-31)117-71(107)26-9-40(85)57(96)41(86)10-26/h1-20,52,63-65,76-101H,21H2/t52-,63-,64+,65-,76+/m1/s1
Canonical SMILES-
信息真实价格透明    资金保障    专业采购外包团队在线服务   
信息真实价格透明    资金保障    专业采购外包团队在线服务   
品牌质保精细包装    现货库存    一流品牌服务   

分类

  • {SNA} Asymmetric Synthesis, Carboxylic Acids, Chemical Synthesis, Chiral Building Blocks, Organic Building Blocks
  • {SNA} Alphabetical Listings, Flavors and Fragrances, Q-Z
  • {SNA} Acids, Acids & Bases, Chemical Synthesis, Organic Acids, Synthetic Reagents
  • {SNA} Acacia, Acids, Acids & Bases,

产品应用

  • 铍、铝、镓、铟、铌、钽和锆的沉淀和重量测定。铜、铁、钒、铈和钴的比定测定。蛋白质及生物碱的沉淀剂。钼酸铵滴定铅时的外指示剂。染料媒染剂。

相关文献及参考

  • Merck: 14,9052

安全信息

WGK Germany2
Precautionary statements
  • P262 Do not get in eyes, on skin, or on clothing. 不要接触眼睛,皮肤或衣服。
  • P264 Wash hands thoroughly after handling. 处理后要彻底洗净双手。
  • P264+P265
  • P273 Avoid release to the environment. 避免释放到环境中。
  • P280 Wear protective gloves/protective clothing/eye protection/face protection. 戴防护手套/防护服/眼睛的保护物/面部保护物。
  • P305+P351+P338
  • P337+P313
  • P337+P317
  • P501 Dispose of contents/container to..… 处理内容物/容器.....
Hazard statements
  • H319 Causes serious eye irritation 严重刺激眼睛
  • H412 Harmfutoaquaticlifewithlonglastingeffects 对水生生物有害并具有长期影响。
RTECSWW5075000
Personal Protective Equipment Eyeshields, Gloves, type N95 (US), type P1 (EN143) respirator filter
Storage condition 4 4°C 4°C, Hygroscopic Air & Light Sensitive 避光保存
Safety Statements
  • S24/25 Avoid contact with skin and eyes 避免皮肤和眼睛接触;
Risk Statements
  • R68 Possible risk of irreversible effects 可能有不可挽回的作用的危险
  • R62 Possible risk of impaired fertility 有削弱生殖能力的危险
  • R63 Possible risk of harm to the unborn child 可能危害未出生婴儿
  • R36/37/38 Irritating to eyes, respiratory system and skin 对眼睛、呼吸系统和皮肤有刺激性
  • R40 Limited evidence of a carcinogenic effect 有限证据表明其致癌作用
  • R52/53
Hazard Codes Xi,Xn
GHS Symbol
TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Subcutaneous
SPECIES OBSERVED        : Rodent - rat
DOSE/DURATION           : 4450 mg/kg/17W-I
TOXIC EFFECTS :
   Tumorigenic - Carcinogenic by RTECS criteria
   Liver - hepatitis, fibrous (cirrhosis, post-necrotic scarring)
   Liver - other changes
REFERENCE :
   AMSHAR Acta Morphologica Academiae Scientiarum Hungaricae.  (Budapest,
   Hungary)  V.1-30, 1951-82.  Volume(issue)/page/year: 3,353,1953

T

TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Subcutaneous
SPECIES OBSERVED        : Rodent - mouse
DOSE/DURATION           : 750 mg/kg/12W-I
TOXIC EFFECTS :
   Tumorigenic - equivocal tumorigenic agent by RTECS criteria
   Liver - tumors
   Tumorigenic - tumors at site of application
REFERENCE :
   BJCAAI British Journal of Cancer.  (Macmillan Press Ltd., Houndmills,
   Basingstoke, Hants. RG21 2XS, UK)  V.1-    1947-  Volume(issue)/page/year:
   14,147,1960

TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Subcutaneous
SPECIES OBSERVED        : Rodent - rat
DOSE/DURATION           : 350 mg/kg/12W-I
TOXIC EFFECTS :
   Tumorigenic - equivocal tumorigenic agent by RTECS criteria
   Tumorigenic - tumors at site of application
REFERENCE :
   BJCAAI British Journal of Cancer.  (Macmillan Press Ltd., Houndmills,
   Basingstoke, Hants. RG21 2XS, UK)  V.1-    1947-  Volume(issue)/page/year:
   14,147,1960

TYPE OF TEST            : TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE       : Subcutaneous
SPECIES OBSERVED        : Rodent - rat
DOSE/DURATION           : 4286 mg/kg/20W-I
TOXIC EFFECTS :
   Tumorigenic - equivocal tumorigenic agent by RTECS criteria
   Liver - other changes
   Liver - tumors
REFERENCE :
   AMSHAR Acta Morphologica Academiae Scientiarum Hungaricae.  (Budapest,
   Hungary)  V.1-

TYPE OF TEST            : LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE       : Subcutaneous
SPECIES OBSERVED        : Rodent - mouse
DOSE/DURATION           : 75 mg/kg
TOXIC EFFECTS :
   Sense Organs and Special Senses (Eye) - hemorrhage
   Lungs, Thorax, or Respiration - respiratory depression
   Nutritional and Gross Metabolic - body temperature decrease
REFERENCE :
   JPETAB Journal of Pharmacology and Experimental Therapeutics.  (Williams &
   Wilkins Co., 428 E. Preston St., Baltimore, MD 21202)  V.1-    1909/10-
   Volume(issue)/page/year: 77,63,1943

TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Subcutaneous
SPECIES OBSERVED        : Rodent - mouse
DOSE/DURATION           : >1600 mg/kg
TOXIC EFFECTS :
   Details of toxic effects not reported other than lethal dose value
REFERENCE :
   JPPMAB Journal of Pharmacy and Pharmacology.  (Pharmaceutical Soc. of Great
   Britain, 1 Lambeth High St., London SEI 7JN, UK)  V.1-    1949-
   Volume(issue)/page/year: 9,98,1957

TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Intravenous
SPECIES OBSERVED        : Rodent - mouse
DOSE/DURATION           : 130 mg/kg
TOXIC EFFECTS :
   Details of toxic effects not reported other than lethal dose value
REFERENCE :
   JPPMAB Journal of Pharmacy and Pharmacology.  (Pharmaceutical Soc. of Great
   Britain, 1 Lambeth High St., London SEI 7JN, UK)  V.1-    1949-
   Volume(issue)/page/year: 9,98,1957

TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Oral
SPECIES OBSERVED        : Rodent - rabbit
DOSE/DURATION           : 5 gm/kg
TOXIC EFFECTS :
   Gastrointestinal - gastritis
   Lungs, Thorax, or Respiration - chronic pulmonary edema
REFERENCE :
   AJVRAH American Journal of Veterinary Research.  (American Veterinary
   Medical Assoc., 930 N. Meacham Rd., Schaumburg, IL

TYPE OF TEST            : Unscheduled DNA synthesis
ROUTE OF EXPOSURE       : Oral
TEST SYSTEM             : Rodent - rat
DOSE/DURATION           : 25 gm/kg
REFERENCE :
   JJIND8 JNCI, Journal of the National Cancer Institute.  (Washington, DC)
   V.61-79, 1978-87. For publisher information, see JNCIEQ.
   Volume(issue)/page/year: 74,1283,1985

TYPE OF TEST            : DNA inhibition
ROUTE OF EXPOSURE       : Intraperitoneal
TEST SYSTEM             : Rodent - mouse
DOSE/DURATION           : 76 mg/kg
REFERENCE :
   IJEBA6 Indian Journal of Experimental Biology.  (Publications & Information
   Directorate, CSIR, Hillside Rd., New Delhi 110 012, India)  V.1-    1963-
   Volume(issue)/page/year: 17,1141,1979

TYPE OF TEST            : Mutation test systems - not otherwise specified
ROUTE OF EXPOSURE       : Oral
TEST SYSTEM             : Rodent - rat
DOSE/DURATION           : 2 gm/kg
REFERENCE :
   FCTXAV Food and Cosmetics Toxicology.  (London, UK)  V.1-19, 1963-81.  For
   publisher information, see FCTOD7.  Volume(issue)/page/year: 14,565,1976

TYPE OF TEST            : Unscheduled DNA synthesis
ROUTE OF EXPOSURE       : Subcutaneous
TEST SYSTEM             : Rodent - rat
DOSE/DURATION           : 375 mg/kg
REFERENCE :
   MUREAV Mutation Research.  (Elsevier Science Pub. B.V., POB 211, 1000 AE
   Amsterdam, Netherlands) V.1-    1964-  Volume(issue)/page/year: 320,189,1994

TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Subcutaneous
SPECIES OBSERVED        : Rodent - rat
DOSE                    : 5 mg/kg
SEX/DURATION            : female 1 day(s) pre-mating
TOXIC EFFECTS :
   Reproductive - Maternal Effects - ovaries, fallopian tubes
REFERENCE :
   ENDOAO Endocrinology (Baltimore).  (Williams & Wilkins Co., 428 E. Preston
   St., Baltimore, MD 21203) V.1-    1917-  Volume(issue)/page/year:
   57,466,1955

TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Oral
SPECIES OBSERVED        : Rodent - rat
DOSE                    : 112 gm/kg
SEX/DURATION            : female 49 day(s) pre-mating
                          female 1-21 day(s) after conception
TOXIC EFFECTS :
   Reproductive - Effects on Newborn - live birth index (measured after birth)
   Reproductive - Effects on Newborn - growth statistics (e.g.%, reduced weight
   gain)
REFERENCE :
   CRSBAW Comptes Rendus des Seances de la Societe de Biologie et de Ses
   Filiales.  (SPPIF, B.P.22, F-41353 Vineuil, France)  V.1-    1849-
   Volume(issue)/page/year: 172,470,1978

TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Oral
SPECIES OBSERVED        : Rodent - mouse
DOSE                    : 1478 gm/kg
SEX/DURATION            : male 11 week(s) pre-mating
                          female 11 week(s) pre-mating
TOXIC EFFECTS :
   Reproductive - Effects on Newborn - live birth index (measured after birth)
   Reproductive - Effects on Newborn - viability index (e.g., # alive at day 4
   per # born alive)
   Reproductive - Effects on Newborn - weaning or lactation index (e.g., #
   alive at weaning per # alive at day 4)
REFERENCE :
   CPGPAY Comparative and General Pharmacology.  (Oxford, UK)  V.1-5, 1970-74.
   For publisher information, see GEPHDP.  Volume(issue)/page/year: 4,393,1973

其他信息

  • 工业单宁酸和药用单宁酸的作用:单宁酸主要用作染色中的媒染剂,也用以制取棓酸、焦棓酸,还可以制造皮革鞣剂、橡胶凝固剂、蛋白质和生物碱沉淀剂,以及测定铍、铝、镍、铜等金属的试剂。 五倍子的水浸提液经蒸发、干燥而得的淡黄色至浅棕色的无定形粉末就是工业单宁酸,含单宁酸80%以上,还含少量的没食子酸、间双没食子酸、三没食子酸和五倍酰葡萄糖等。单宁酸是以1,3,4,6-四-O-没食子酰-2-多-O-没食子酰-β-D葡萄糖为核心,由1个分子的葡萄糖与8~9个没食子酸结合而成的酯。单宁酸易被酸或酶水解,水解产物为没食子酸和葡萄糖。 工业单宁酸的主要作用如下: ①作没食子酸和焦性没食子酸原料。 ②媒染剂。用于纤维固色或染色, 作盐基性染料。 ③矿石浮选剂。稀有金属冶炼,从铅锌矿或烟尘中提锗, 从溶液中提取钍、钋等稀有金属, 从黄铜矿中提铅和铜。 ④转化涂料。铝及其合金制板、钢铁、铜、锌表面防蚀等。 ⑤食品添加剂。如食品抗氧化剂、饮料澄清剂、高级墨水和油墨。 ⑥钻井泥浆稀释剂。 ⑦增效剂。合成2,4-二氨基-5-(3,4,5-三甲氧苄二氨嘧啶)(trimethoprimam), 简称TMP或磺胺增效剂。 ⑧除臭剂。用于冰箱、库房、厕所除氨气等臭味。此外,单宁酸还可以合成克冠二胺、克冠卓等心脏疾病用药;合成联苯双酯,治疗乙型肝炎;合成锑-273,治疗血吸虫病。 单宁酸可抑制细菌生长及肠内毒素的吸收,可用于防治腹泻等。药用单宁酸可直接用于饮料、冷冻制品、糖果、冰淇淋、肉类制品;作烧伤、烫伤创面收敛剂、肠胃止血剂,防止感染;可制成鞣酸甘油、鞣酸蛋白、鞣酸软膏、防感冒剂(N-双脒基吗啉单宁酸盐)、健康促进剂、驱虫剂、杀虫剂、防辐射药剂、避孕药剂及特效牙膏等。
  • {Che
  • 五倍子:五倍子是由瘿绵蚜科的一些种蚜虫,寄生在漆树科盐肤木属
  • 理化性质:单宁酸又称中国单宁、鞣酸、五棓子单宁酸。结构至今尚不清楚,一般认为是葡萄糖的五个羟基和没食子酰没食子酰基结合而成的酯。五倍子经过浸提,浓缩后即可制成工业用单宁酸。再经精制后可制成药用或试剂单宁酸。 单宁酸为淡黄色无定形粉末或有光泽的鳞片状或海绵状固体。无特殊气味,有苦涩味,具收敛性。暴露于空气及日光中逐渐变黑。溶于冷水,在热水中能无限地溶解;能溶于甲醇、乙醇、丙酮和乙酸乙酯,不溶于苯、乙醚、氯仿、石油醚及二硫化碳中。单宁酸水溶液呈弱酸性,容易氧化,在碱性溶液中氧化更快,溶液颜色更深。遇三价铁离子,溶液呈蓝黑色,与白明胶、生物碱作用产生沉淀。与铅、铝、锌、锗等金属离子作用生成多核络合物,具有特殊颜色的不溶性盐类。单宁酸加热到210~215℃时分解为焦性没食子酸和CO2。单宁酸低毒,但大量摄取可引起呕吐、腹痛、腹泻,并可导致循环系统障碍致死,LD1006.0g/kg(家鼠,经口)。在高温下可分解生成连苯三酚和二氧化碳。市面上销售的单宁酸通常含10%水分。 图1为单宁酸化学结构式 以上信息由Chemicalbook的彤彤编辑整理
  • 简史:公元734年(唐开元二十二年),陈藏器在《本草拾遗》中已将五倍子列入药典。明李时珍著《本草纲目》中对五倍子有过“皮工造为百药煎,以染皂色,大为时用”的记载。1862年五倍子远到欧洲。1887年密尔仁斯克(S.Mierzinski)曾利用中国五倍子提取单宁作鞣料。1936年李福华等人著文介绍中国五倍子及其利用情况。1940年前后中国黄海化学工业社吴冰颜、魏文德、方心芳等人研究五倍子提取单宁与发酵制没食子酸的方法。同期,在上海、重庆两地设厂生产单宁酸和没食子酸。1957年上海仁记化工厂迁到五倍子产地贵州,在遵义市建成第二化工厂继续生产。1988年湖北应用新工艺、新设备在竹山县建成现代化单宁酸(系列产品)厂。河南、陕西、湖南、云南等省还有几家规模小的单宁车间,全国单宁酸厂(车间)年生产能力约3000吨。 土耳其、秘鲁、委内瑞拉自18世纪30年代起,先后利用土耳其棓子(
  • 图谱信息:单宁酸(1401-55-4)红外图谱(IR1) 单宁酸(1401-55-4)红外图谱(IR2) 单宁酸(1401-55-4)质谱(MS)
  • EPA化学物质信息:Tannins(1401-55-4)
  • FEMA:3042
  • 稳定性:Stable. Incompatible with metallic salts, strong oxidizing agents, iron and other heavy metals.

系列性分类


相关产品推荐